MIRA Announces Positive Test Results

Loading... READ THE FULL MIRA RESEARCH REPORT The company announced that it achieved positive preclinical study results for Ketamir-2, its Novel Oral ketamine Analog. The company characterized these results as "highly encouraging" and are as follows, as reported by MIRA: A) Mice treated with Ketamir-2 showed dose-related, significantly greater locomotor activity, higher travel speed and a trend towards an increased time spent in the center of the arena, indicating reduced anxiety levels. A) In this model of ...